Brazil’s National Clinical Research Program (PPClin) was established by the Ministry of Health to reorganize, modernize and nationally integrate clinical research. The program seeks to accelerate the development of drugs and therapies, increase patient diversity in clinical trials, strengthen transparency, monitoring and technological innovation, and expand access for the Brazilian population to new health solutions.